Cross Country Healthcare, Inc. (NASDAQ: CCRN - Get Free Report) has been assigned a consensus rating of "Hold" from the nine analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have issued a buy recommendation on the company. The
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country and Open Hearts for Orphans unite to support families, strengthen communities, and improve outcomes for vulnerable children.
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cross Country Healthcare, Inc. (CCRN) Q4 2025 Earnings Call Transcript
Cross Country Healthcare (CCRN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.04 per share a year ago.
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company,” “Cross Country,” “we,” “us,” and “our”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761 (24 ) % (5 ) % $ 1,054,293 (22 ) % Gross profit ma.
Broker upgrades and rising earnings estimates highlight stocks like ARW, GOLD, CCRN, AMN and PENN amid geopolitical tensions and tech-sector volatility.
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Truist Securities Virtual Human Capital Conference taking place March 12-13, 2026, with one-on-one investor meetings on Thursday, March 12. The Oppenheimer 36th Annual Healthcare MedTech & Services Conference taking place March 16-19, 2026, with one-on-one investor meetings on Tuesday, March 17. In attendance an.
AI fears and geopolitical jitters rattle markets, but broker-loved picks like Arrow Electronics and some others stand out on upgrades and earnings momentum.
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, March 4, 2026 at 5:00 P.M. Eastern Time. Cross Country Healthcare, Inc. (the “Company”) intends to distribute its earnings press release after market close on Wednesday, March 4, 2026. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing.
Heidrick and Struggles International (NASDAQ: HSII - Get Free Report) and Cross Country Healthcare (NASDAQ: CCRN - Get Free Report) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership and dividends. Valuation and Earnings
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country”) (Nasdaq: CCRN) today announced that John A. Martins, the Company's President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the “Board”), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company's current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Compan.
Caxton Associates LLP bought a new stake in Cross Country Healthcare, Inc. (NASDAQ: CCRN) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 205,143 shares of the business services provider's stock, valued at approximately $2,677,000. Caxton Associates LLP owned approximately 0.63% of Cross
Cross Country Healthcare (NASDAQ: CCRN - Get Free Report) and Randstad (OTCMKTS:RANJY - Get Free Report) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability. Profitability This table compares Cross Country Healthcare
Cross Country Healthcare saw its merger with Aya Healthcare collapse after the government shutdown pushed back the HSR waiting period expiration date. CCRN will receive a $20 million termination fee from Aya, adding to an already formidable cash position. Management has announced that it will immediately undergo up to $40 million in share buybacks, capitalizing on a low stock price.
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country Healthcare”) (Nasdaq: CCRN) today announced the termination of its Agreement and Plan of Merger (the “Merger Agreement” and, the transactions contemplated thereby, the “Aya Merger”) with Aya Holdings II Inc., a Delaware corporation (“Parent”), Spark Merger Sub One Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and, solely for purposes of Section 11.14 thereto.
Groupe la Francaise raised its holdings in Cross Country Healthcare, Inc. (NASDAQ: CCRN) by 77.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 186,159 shares of the business services provider's stock after acquiring an additional 81,000 shares during the quarter. Groupe la
Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.12 per share a year ago.
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025. Selected Financial Information: Variance Variance Q3 2025 vs Q3 2025 vs Dollars are in thousands, except per share amounts Q3 2025 Q3 2024 Q2 2025 Revenue $ 250,052 (21 )% (9 )% Gross profit margin* 20.4 % — bps — bps Net loss attributable to common stockholders $ (4,774 ) (287 )% 28 % Diluted EPS.